Avanos Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -34.0% | +93.4% | -23.6% | -201.0% | – | – | – | +4.1% | -64.4% | +210.8% | -25.8% | |
| – | -23.4% | -0.3% | -8.7% | -43.7% | +10.1% | +16.3% | -10.7% | +24.5% | -3.4% | -1.3% | -14.5% | |
| – | +78.5% | +5.0% | -14.9% | -16.7% | +0.0% | +15.2% | +9.1% | +20.5% | -0.6% | -12.7% | -8.7% | |
| – | +2,381.4% | -96.2% | -14.1% | -643.4% | – | +222.5% | -40.8% | -19.8% | – | – | – | |
| – | -232.8% | – | -104.7% | – | – | – | – | -193.5% | – | – | -72.0% | |
| – | -10.3% | -58.7% | +48.5% | +13.7% | +3.1% | -60.1% | +4.0% | -8.1% | -7.8% | +0.0% | +77.5% | |
| – | -11.5% | +220.9% | -78.5% | – | -116.9% | -77.6% | -13.2% | +544.8% | – | -227.3% | +120.4% | |
| – | -100.0% | – | – | – | – | -35.8% | +82.4% | -72.6% | – | – | – | |
| – | – | -10.0% | +177.8% | -64.0% | +300.0% | -75.0% | +1,177.8% | +295.7% | -58.0% | -33.0% | -74.2% | |
| – | -108.2% | -98.2% | +37,566.7% | +0.5% | -99.9% | +34,800.0% | -28.4% | – | -164.4% | -48.1% | +2.4% | |
| – | -273.3% | -97.2% | – | -14,845.5% | – | -4,766.7% | -21.0% | – | -266.1% | -47.9% | -24.6% | |
| – | -118.6% | – | – | +55.5% | -208.7% | – | – | +31.4% | -534.8% | – | -189.5% | |
| – | -60.8% | +487.1% | -36.8% | -292.8% | – | – | – | +8.0% | -79.6% | +467.8% | -48.0% |
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.